Conclusions
The present work establishes P-I as an agent with a strong effect against breast cancer in a preclinical model, suggests that the mode of its delivery may be important for its efficacy, and establishes the Trx system as a critical mediator of its mechanism of action. The Trx system, vital for cell homeostasis, emerges as an important target for the development of novel anti-cancer agents.